{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:35:03Z","timestamp":1791909303907,"version":"4.3.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"24","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["#IRG 85-001-25"],"award-info":[{"award-number":["#IRG 85-001-25"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["5P20GM121327-03"],"award-info":[{"award-number":["5P20GM121327-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,7,1]]},"DOI":"10.1038\/s41388-026-03780-2","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:42:56Z","timestamp":1777495376000},"page":"2327-2341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Crosstalk between integrin signaling and NAD\u207a biosynthetic pathways promotes glycolysis, proliferation, survival, and tumor growth in triple-negative breast cancer"],"prefix":"10.1038","volume":"45","author":[{"given":"Orion","family":"Spellecy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javeria","family":"Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongbo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Aryal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruei-Lung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abu Saleh Mosa","family":"Faisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6507-6932","authenticated-orcid":false,"given":"Dana","family":"Napier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dava","family":"Piecoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence D.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8713-3599","authenticated-orcid":false,"given":"Natasha","family":"Kyprianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2892-7209","authenticated-orcid":false,"given":"Burton B.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7636-2484","authenticated-orcid":false,"given":"Xiuwei H.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"3780_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42748-8","volume":"14","author":"CM Young","year":"2023","unstructured":"Young CM, Beziaud L, Dessen P, Madurga Alonso A, Santamaria-Martinez A, Huelsken J. Metabolic dependencies of metastasis-initiating cells in female breast cancer. Nat Commun. 2023;14:7076.","journal-title":"Nat Commun"},{"key":"3780_CR2","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.cell.2020.10.036","volume":"183","author":"K Krug","year":"2020","unstructured":"Krug K, Jaehnig EJ, Satpathy S, Blumenberg L, Karpova A, Anurag M, et al. Proteogenomic landscape of breast cancer tumorigenesis and targeted therapy. Cell. 2020;183:1436\u201356.e1431.","journal-title":"Cell"},{"key":"3780_CR3","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1158\/2159-8290.CD-22-0200","volume":"12","author":"M Anurag","year":"2022","unstructured":"Anurag M, Jaehnig EJ, Krug K, Lei JT, Bergstrom EJ, Kim BJ, et al. Proteogenomic markers of chemotherapy resistance and response in triple-negative breast cancer. Cancer Discov. 2022;12:2586\u2013605.","journal-title":"Cancer Discov"},{"key":"3780_CR4","doi-asserted-by":"crossref","unstructured":"Fallah Y, Brundage J, Allegakoen P, Shajahan-Haq AN. MYC-driven pathways in breast cancer subtypes. Biomolecules 2017;7:53\u22128.","DOI":"10.3390\/biom7030053"},{"key":"3780_CR5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1158\/0008-5472.CAN-21-2807","volume":"82","author":"S Bhatia","year":"2022","unstructured":"Bhatia S, Kramer M, Russo S, Naik P, Arun G, Brophy K, et al. Patient-derived triple-negative breast cancer organoids provide robust model systems that recapitulate tumor intrinsic characteristics. Cancer Res. 2022;82:1174\u201392.","journal-title":"Cancer Res"},{"key":"3780_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34:355\u201377.","journal-title":"Cell Metab"},{"key":"3780_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21:141\u201362.","journal-title":"Nat Rev Drug Discov"},{"key":"3780_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10350","volume":"476","author":"R Possemato","year":"2011","unstructured":"Possemato R, Marks KM, Shaul YD, Pacold ME, Kim D, Birsoy K, et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature. 2011;476:346\u201350.","journal-title":"Nature"},{"key":"3780_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40170-017-0168-x","volume":"5","author":"NJ Lanning","year":"2017","unstructured":"Lanning NJ, Castle JP, Singh SJ, Leon AN, Tovar EA, Sanghera A, et al. Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities. Cancer Metab. 2017;5:6.","journal-title":"Cancer Metab"},{"key":"3780_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1158\/0008-5472.CAN-21-2745","volume":"82","author":"C Liao","year":"2022","unstructured":"Liao C, Glodowski CR, Fan C, Liu J, Mott KR, Kaushik A, et al. Integrated metabolic profiling and transcriptional analysis reveals therapeutic modalities for targeting rapidly proliferating breast cancers. Cancer Res. 2022;82:665\u201380.","journal-title":"Cancer Res"},{"key":"3780_CR11","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cmet.2019.08.013","volume":"30","author":"J Kim","year":"2019","unstructured":"Kim J, DeBerardinis RJ. Mechanisms and implications of metabolic heterogeneity in cancer. Cell Metab. 2019;30:434\u201346.","journal-title":"Cell Metab"},{"key":"3780_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper J, Giancotti FG. Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell. 2019;35:347\u201367.","journal-title":"Cancer Cell"},{"key":"3780_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673\u201387.","journal-title":"Cell"},{"key":"3780_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/36349","volume":"390","author":"CA Fenczik","year":"1997","unstructured":"Fenczik CA, Sethi T, Ramos JW, Hughes PE, Ginsberg MH. Complementation of dominant suppression implicates CD98 in integrin activation. Nature. 1997;390:81\u201385.","journal-title":"Nature"},{"key":"3780_CR15","first-page":"252","volume":"119","author":"Y Pylayeva","year":"2009","unstructured":"Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, Giancotti FG. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest. 2009;119:252\u201366.","journal-title":"J Clin Invest"},{"key":"3780_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature08268","volume":"461","author":"ZT Schafer","year":"2009","unstructured":"Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature. 2009;461:109\u201313.","journal-title":"Nature"},{"key":"3780_CR17","doi-asserted-by":"crossref","unstructured":"Rigiracciolo DC, Cirillo F, Talia M, Muglia L, Gutkind JS, Maggiolini M, et al. Focal adhesion kinase fine tunes multifaced signals toward breast cancer progression. Cancers 2021;13:645\u22124.","DOI":"10.3390\/cancers13040645"},{"key":"3780_CR18","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s13402-020-00537-1","volume":"43","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xu B, Shi J, Li J, Lu X, Xu L, et al. BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways. Cell Oncol. 2020;43:1049\u201366.","journal-title":"Cell Oncol"},{"key":"3780_CR19","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s44319-023-00033-1","volume":"25","author":"D Das","year":"2024","unstructured":"Das D, Leung JY, Balamurugan S, Tergaonkar V, Loh AHP, Chiang CM, et al. BRD4 isoforms have distinct roles in tumour progression and metastasis in rhabdomyosarcoma. EMBO Rep. 2024;25:832\u201352.","journal-title":"EMBO Rep"},{"key":"3780_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0915-9","volume":"17","author":"B Donati","year":"2018","unstructured":"Donati B, Lorenzini E, Ciarrocchi A. BRD4 and Cancer: going beyond transcriptional regulation. Mol Cancer. 2018;17:164.","journal-title":"Mol Cancer"},{"key":"3780_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/JLB.5RI0917-380RR","volume":"104","author":"GP Andrieu","year":"2018","unstructured":"Andrieu GP, Shafran JS, Deeney JT, Bharadwaj KR, Rangarajan A, Denis GV. BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment. J Leukoc Biol. 2018;104:265\u201374.","journal-title":"J Leukoc Biol"},{"key":"3780_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","volume":"22","author":"C Canto","year":"2015","unstructured":"Canto C, Menzies KJ, Auwerx J. NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 2015;22:31\u201353.","journal-title":"Cell Metab"},{"key":"3780_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/srep06107","volume":"4","author":"T Zhou","year":"2014","unstructured":"Zhou T, Wang T, Garcia JG. Expression of nicotinamide phosphoribosyltransferase-influenced genes predicts recurrence-free survival in lung and breast cancers. Sci Rep. 2014;4:6107.","journal-title":"Sci Rep"},{"key":"3780_CR24","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41416-024-02889-z","volume":"131","author":"HN Girithar","year":"2024","unstructured":"Girithar HN, Krishnamurthy S, Carroll L, Guller A, Bilgin AA, Gluch L, et al. Breast cancer metastasis progression is associated with elevated activity of kynurenine monooxygenase and kynureninase. Br J Cancer. 2024;131:1881\u201392.","journal-title":"Br J Cancer"},{"key":"3780_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41416-023-02245-7","volume":"129","author":"HN Girithar","year":"2023","unstructured":"Girithar HN, Staats Pires A, Ahn SB, Guillemin GJ, Gluch L, Heng B. Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials. Br J Cancer. 2023;129:185\u2013203.","journal-title":"Br J Cancer"},{"key":"3780_CR26","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.cmet.2021.04.003","volume":"33","author":"CCS Chini","year":"2021","unstructured":"Chini CCS, Zeidler JD, Kashyap S, Warner G, Chini EN. Evolving concepts in NAD(+) metabolism. Cell Metab. 2021;33:1076\u201387.","journal-title":"Cell Metab"},{"key":"3780_CR27","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/emmm.201201250","volume":"4","author":"I Bajrami","year":"2012","unstructured":"Bajrami I, Kigozi A, Van Weverwijk A, Brough R, Frankum J, Lord CJ, et al. Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells. EMBO Mol Med. 2012;4:1087\u201396.","journal-title":"EMBO Mol Med"},{"key":"3780_CR28","doi-asserted-by":"crossref","unstructured":"Pramono AA, Rather GM, Herman H, Lestari K, Bertino JR NAD- and NADPH-contributing enzymes as therapeutic targets in cancer: an overview. Biomolecules. 2020;10:358\u22126.","DOI":"10.3390\/biom10030358"},{"key":"3780_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40170-018-0174-7","volume":"6","author":"N Thongon","year":"2018","unstructured":"Thongon N, Zucal C, D\u2019Agostino VG, Tebaldi T, Ravera S, Zamporlini F, et al. Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA. Cancer Metab. 2018;6:1.","journal-title":"Cancer Metab"},{"key":"3780_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41586-020-1998-1","volume":"578","author":"JS Park","year":"2020","unstructured":"Park JS, Burckhardt CJ, Lazcano R, Solis LM, Isogai T, Li L, et al. Mechanical regulation of glycolysis via cytoskeleton architecture. Nature. 2020;578:621\u20136.","journal-title":"Nature"},{"key":"3780_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41573-021-00284-4","volume":"21","author":"RJ Slack","year":"2022","unstructured":"Slack RJ, Macdonald SJF, Roper JA, Jenkins RG, Hatley RJD. Emerging therapeutic opportunities for integrin inhibitors. Nat Rev Drug Discov. 2022;21:60\u201378.","journal-title":"Nat Rev Drug Discov"},{"key":"3780_CR32","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41580-024-00752-w","volume":"25","author":"ME Migaud","year":"2024","unstructured":"Migaud ME, Ziegler M, Baur JA. Regulation of and challenges in targeting NAD(+) metabolism. Nat Rev Mol Cell Biol. 2024;25:822\u201340.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3780_CR33","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1593\/neo.12922","volume":"14","author":"X Deng","year":"2012","unstructured":"Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, et al. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. Neoplasia. 2012;14:678\u201389.","journal-title":"Neoplasia"},{"key":"3780_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jcmgh.2019.02.009","volume":"8","author":"J Zhang","year":"2019","unstructured":"Zhang J, Gelman IH, Katsuta E, Liang Y, Wang X, Li J, et al. Glucose Drives Growth Factor-Independent Esophageal Cancer Proliferation via Phosphohistidine-Focal Adhesion Kinase Signaling. Cell Mol Gastroenterol Hepatol. 2019;8:37\u201360.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3780_CR35","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1038\/onc.2015.256","volume":"35","author":"J Zhang","year":"2016","unstructured":"Zhang J, Gao Q, Zhou Y, Dier U, Hempel N, Hochwald SN. Focal adhesion kinase-promoted tumor glucose metabolism is associated with a shift of mitochondrial respiration to glycolysis. Oncogene. 2016;35:1926\u201342.","journal-title":"Oncogene"},{"key":"3780_CR36","doi-asserted-by":"publisher","first-page":"E187","DOI":"10.1073\/pnas.1105304109","volume":"109","author":"A Menssen","year":"2012","unstructured":"Menssen A, Hydbring P, Kapelle K, Vervoorts J, Diebold J, Luscher B, et al. The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc Natl Acad Sci USA. 2012;109:E187\u2013196.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3780_CR37","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2290911","volume":"39","author":"R Cyriac","year":"2024","unstructured":"Cyriac R, Lee K. Glutaminase inhibition as potential cancer therapeutics: current status and future applications. J Enzyme Inhib Med Chem. 2024;39:2290911.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3780_CR38","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2011.12.009","volume":"15","author":"A Le","year":"2012","unstructured":"Le A, Lane AN, Hamaker M, Bose S, Gouw A, Barbi J, et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 2012;15:110\u201321.","journal-title":"Cell Metab"},{"key":"3780_CR39","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1039\/C0MB00294A","volume":"7","author":"AA Seyhan","year":"2011","unstructured":"Seyhan AA, Varadarajan U, Choe S, Liu Y, McGraw J, Woods M, et al. A genome-wide RNAi screen identifies novel targets of neratinib sensitivity leading to neratinib and paclitaxel combination drug treatments. Mol Biosyst. 2011;7:1974\u201389.","journal-title":"Mol Biosyst"},{"key":"3780_CR40","doi-asserted-by":"crossref","unstructured":"Audrito V, Messana VG, Moiso E, Vitale N, Arruga F, Brandimarte L, et al. NAMPT over-expression recapitulates the BRAF inhibitor resistant phenotype plasticity in melanoma. Cancers. 2020;12:3855\u221277.","DOI":"10.3390\/cancers12123855"},{"key":"3780_CR41","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.molcel.2020.04.027","volume":"78","author":"S Shu","year":"2020","unstructured":"Shu S, Wu HJ, Ge JY, Zeid R, Harris IS, Jovanovic B, et al. Synthetic lethal and resistance interactions with BET bromodomain inhibitors in triple-negative breast cancer. Mol Cell. 2020;78:1096\u2013113 e1098.","journal-title":"Mol Cell"},{"key":"3780_CR42","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.neo.2019.07.009","volume":"21","author":"L Brandl","year":"2019","unstructured":"Brandl L, Zhang Y, Kirstein N, Sendelhofert A, Boos SL, Jung P, et al. Targeting c-MYC through interference with NAMPT and SIRT1 and their association to oncogenic drivers in murine serrated intestinal tumorigenesis. Neoplasia. 2019;21:974\u201388.","journal-title":"Neoplasia"},{"key":"3780_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02164-5","volume":"23","author":"M Rodriguez","year":"2025","unstructured":"Rodriguez M, Xu H, Hernandez A, Ingraham J, Canizales J, Arce FT, et al. NEDD4 E3 ligase-catalyzed NAMPT ubiquitination and autophagy activation are essential for pyroptosis-independent NAMPT secretion in human monocytes. Cell Commun Signal. 2025;23:157.","journal-title":"Cell Commun Signal"},{"key":"3780_CR44","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1158\/1535-7163.MCT-16-0794","volume":"16","author":"CG Langdon","year":"2017","unstructured":"Langdon CG, Platt JT, Means RE, Iyidogan P, Mamillapalli R, Klein M, et al. Combinatorial screening of pancreatic adenocarcinoma reveals sensitivity to drug combinations including bromodomain inhibitor plus neddylation inhibitor. Mol Cancer Ther. 2017;16:1041\u201353.","journal-title":"Mol Cancer Ther"},{"key":"3780_CR45","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/j.celrep.2016.07.027","volume":"16","author":"KL Stromsdorfer","year":"2016","unstructured":"Stromsdorfer KL, Yamaguchi S, Yoon MJ, Moseley AC, Franczyk MP, Kelly SC, et al. NAMPT-mediated NAD(+) biosynthesis in adipocytes regulates adipose tissue function and multi-organ insulin sensitivity in mice. Cell Rep. 2016;16:1851\u201360.","journal-title":"Cell Rep"},{"key":"3780_CR46","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cmet.2015.04.002","volume":"21","author":"MJ Yoon","year":"2015","unstructured":"Yoon MJ, Yoshida M, Johnson S, Takikawa A, Usui I, Tobe K, et al. SIRT1-mediated eNAMPT secretion from adipose tissue regulates hypothalamic NAD+ and function in mice. Cell Metab. 2015;21:706\u201317.","journal-title":"Cell Metab"},{"key":"3780_CR47","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121:2750\u201367.","journal-title":"J Clin Invest"},{"key":"3780_CR48","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1016\/j.celrep.2016.10.077","volume":"17","author":"SF Johnson","year":"2016","unstructured":"Johnson SF, Cruz C, Greifenberg AK, Dust S, Stover DG, Chi D, et al. CDK12 Inhibition reverses de novo and acquired PARP inhibitor resistance in BRCA wild-type and mutated models of triple-negative breast cancer. Cell Rep. 2016;17:2367\u201381.","journal-title":"Cell Rep"},{"key":"3780_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0855-0","volume":"19","author":"SE Smith","year":"2017","unstructured":"Smith SE, Mellor P, Ward AK, Kendall S, McDonald M, Vizeacoumar FS, et al. Molecular characterization of breast cancer cell lines through multiple omic approaches. Breast Cancer Res. 2017;19:65.","journal-title":"Breast Cancer Res"},{"key":"3780_CR50","doi-asserted-by":"publisher","first-page":"e0213576","DOI":"10.1371\/journal.pone.0213576","volume":"14","author":"K Davis","year":"2019","unstructured":"Davis K, Dunseth CD, Mott SL, Cramer-Morales KL, Miller AM, Ear PH, et al. Nicotinamide phosphoribosyltransferase expression and clinical outcome of resected stage I\/II pancreatic ductal adenocarcinoma. PLoS One. 2019;14:e0213576.","journal-title":"PLoS One"},{"key":"3780_CR51","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1080\/15548627.2017.1364334","volume":"13","author":"X Wen","year":"2017","unstructured":"Wen X, Klionsky DJ. BRD4 is a newly characterized transcriptional regulator that represses autophagy and lysosomal function. Autophagy. 2017;13:1801\u20133.","journal-title":"Autophagy"},{"key":"3780_CR52","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nchembio.2070","volume":"12","author":"ME Pacold","year":"2016","unstructured":"Pacold ME, Brimacombe KR, Chan SH, Rohde JM, Lewis CA, Swier LJ, et al. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat Chem Biol. 2016;12:452\u20138.","journal-title":"Nat Chem Biol"},{"key":"3780_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.132","volume":"8","author":"LQ Zhang","year":"2017","unstructured":"Zhang LQ, Van Haandel L, Xiong M, Huang P, Heruth DP, Bi C, et al. Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase. Cell Death Dis. 2017;8:e2705.","journal-title":"Cell Death Dis"},{"key":"3780_CR54","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/gtc.12542","volume":"22","author":"FD Khaidizar","year":"2017","unstructured":"Khaidizar FD, Nakahata Y, Kume A, Sumizawa K, Kohno K, Matsui T, et al. Nicotinamide phosphoribosyltransferase delays cellular senescence by upregulating SIRT1 activity and antioxidant gene expression in mouse cells. Genes Cells. 2017;22:982\u201392.","journal-title":"Genes Cells"},{"key":"3780_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13172-8","volume":"10","author":"EF Fang","year":"2019","unstructured":"Fang EF, Hou Y, Lautrup S, Jensen MB, Yang B, SenGupta T, et al. NAD(+) augmentation restores mitophagy and limits accelerated aging in Werner syndrome. Nat Commun. 2019;10:5284.","journal-title":"Nat Commun"},{"key":"3780_CR56","doi-asserted-by":"crossref","unstructured":"Gao C, Chen G, Kuan SF, Zhang DH, Schlaepfer DD, Hu J FAK\/PYK2 promotes the Wnt\/beta-catenin pathway and intestinal tumorigenesis by phosphorylating GSK3beta. Elife. 2015;4:e10072\u221210089.","DOI":"10.7554\/eLife.10072"},{"key":"3780_CR57","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-019-1150-2","volume":"569","author":"S Chowdhry","year":"2019","unstructured":"Chowdhry S, Zanca C, Rajkumar U, Koga T, Diao Y, Raviram R, et al. NAD metabolic dependency in cancer is shaped by gene amplification and enhancer remodelling. Nature. 2019;569:570\u20135.","journal-title":"Nature"},{"key":"3780_CR58","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov. 2019;9:176\u201398.","journal-title":"Cancer Discov"},{"key":"3780_CR59","doi-asserted-by":"crossref","unstructured":"Daniels VW, Zoeller JJ, van Gastel N, McQueeney KE, Parvin S, Potter DS, et al. Metabolic perturbations sensitize triple-negative breast cancers to apoptosis induced by BH3 mimetics. Sci Signal. 2021;14:eabc7405-7419.","DOI":"10.1126\/scisignal.abc7405"},{"key":"3780_CR60","doi-asserted-by":"crossref","unstructured":"Novak Kujundzic R, Prpic M, Dakovic N, Dabelic N, Tomljanovic M, Mojzes A et al. Nicotinamide N-Methyltransferase in Acquisition of Stem Cell Properties and Therapy Resistance in Cancer. Int J Mol Sci. 2021;22:5681\u22125702.","DOI":"10.3390\/ijms22115681"},{"key":"3780_CR61","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/neuonc\/noab175","volume":"24","author":"P Sharma","year":"2022","unstructured":"Sharma P, Xu J, Williams K, Easley M, Elder JB, Lonser R, et al. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress. Neuro Oncol. 2022;24:229\u201344.","journal-title":"Neuro Oncol"},{"key":"3780_CR62","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fonc.2019.00292","volume":"9","author":"A Lucena-Cacace","year":"2019","unstructured":"Lucena-Cacace A, Umeda M, Navas LE, Carnero A. NAMPT as a Dedifferentiation-inducer gene: NAD(+) as core axis for glioma cancer stem-like cells maintenance. Front Oncol. 2019;9:292.","journal-title":"Front Oncol"},{"key":"3780_CR63","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/0008-5472.CAN-19-2830","volume":"80","author":"T Nacarelli","year":"2020","unstructured":"Nacarelli T, Fukumoto T, Zundell JA, Fatkhutdinov N, Jean S, Cadungog MG, et al. NAMPT inhibition suppresses cancer stem-like cells associated with therapy-induced senescence in ovarian cancer. Cancer Res. 2020;80:890\u2013900.","journal-title":"Cancer Res"},{"key":"3780_CR64","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/carcin\/bgy174","volume":"40","author":"A Banerjee","year":"2019","unstructured":"Banerjee A, Birts CN, Darley M, Parker R, Mirnezami AH, West J, et al. Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization. Carcinogenesis. 2019;40:871\u201382.","journal-title":"Carcinogenesis"},{"key":"3780_CR65","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.celrep.2019.03.024","volume":"27","author":"H Muraoka","year":"2019","unstructured":"Muraoka H, Hasegawa K, Sakamaki Y, Minakuchi H, Kawaguchi T, Yasuda I, et al. Role of Nampt-Sirt6 Axis in Renal Proximal Tubules in Extracellular Matrix Deposition in Diabetic Nephropathy. Cell Rep. 2019;27:199\u2013212.e195.","journal-title":"Cell Rep"},{"key":"3780_CR66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41392-020-00354-w","volume":"6","author":"LE Navas","year":"2021","unstructured":"Navas LE, Carnero A. NAD(+) metabolism, stemness, the immune response, and cancer. Signal Transduct Target Ther. 2021;6:2.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03780-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03780-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03780-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:02:36Z","timestamp":1781042556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03780-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":66,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026,7,1]]}},"alternative-id":["3780"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03780-2","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"31 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}